Hydroxyapatite Antibody Purification for Clipped Variant Separation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods struggle to efficiently purify recombinant antibodies from degradation products that have similar molecular properties, making it difficult to separate intact antibodies from clipped versions at large scale.
Innovation Solution
Utilizing hydroxyapatite (HA) resin for antibody purification, where the antibody preparation is loaded onto the resin, washed, and then eluted using a phosphate buffer gradient to effectively separate intact antibodies from clipped or degraded forms.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional purification methods are used, then the purification process is simple, but the separation efficiency between intact antibody and clipped antibody is poor
Solution Approach 1:
The patent applies parameter changes by utilizing a phosphate gradient elution method where the phosphate concentration is gradually increased from 0 to 500mM. This gradual change in ionic strength parameter allows differential elution of intact antibodies versus clipped antibodies based on their binding affinities to the hydroxyapatite resin, achieving effective separation without requiring complex multi-step procedures
Solution Approach 2:
The patent employs hydroxyapatite resin as an intermediary material that mediates the separation process. The resin's unique surface properties enable it to differentially bind intact antibodies and clipped antibodies, allowing them to be separated through controlled elution while maintaining a relatively simple purification system
2Quantity of substance
If hydroxyapatite resin with high phosphate capacity is used, then the purification capacity increases, but the risk of antibody aggregation increases
Solution Approach 1:
The patent applies dynamics by implementing a gradual phosphate gradient elution rather than a sudden high-phosphate shock. The phosphate concentration increases progressively from 0 to 500mM, allowing antibodies to elute in a controlled manner based on their binding strengths. This dynamic approach prevents sudden conformational changes that could lead to aggregation, while still achieving high purification capacity through the use of high-phosphate-capacity hydroxyapatite resin
Solution Approach 2:
The patent employs beforehand cushioning by using a gradual phosphate gradient that acts as a buffer between the bound antibodies and the high-phosphate elution conditions. This gradual transition cushions the antibodies against sudden environmental changes that could cause aggregation, while the high-phosphate-capacity resin ensures sufficient purification capacity is maintained throughout the process
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Achieves high-purity purification of antibodies, with the purified fraction containing at least 80% intact antibody and minimal clipped antibody, effectively addressing the separation challenge.
Implementation Method 1
loading an antibody preparation in a load buffer onto a hydroxyapatite (HA) resin... eluting the intact antibody of interest from the HA resin with an elution buffer
Data Source
AI summary
Antibody compositions and methods for the purification of antibodies are provided. Purification methods provided involve the use of hydroxyapatite resin (HA) to separate an antibody of interest from one or more impurities.